China Biopharma, Inc., a development stage company, engages in the development and marketing of human vaccines and other pharmaceutical products in the People's Republic of China. The company has an agreement to distribute Serrapeptase tablets manufactured by Takeda Pharmaceutical Company, Ltd. It distributes vaccines and other pharmaceutical products directly or indirectly primarily to hospitals, clinics, and pension fund health programs. The company was founded in 1997 and is based in Hangzhou, the People's Republic of China.